Visit the Harvest One Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
Harvest One’s Wholly Owned Subsidiary United Greeneries Receives ACMPR Sales and Distribution Amendment from Health Canada
VANCOUVER, British Columbia, Oct. 13, 2017 (GLOBE NEWSWIRE) — Harvest One Cannabis Inc. (TSXV:HVST) (“Harvest One” or the “Company”) through its wholly owned subsidiary United Greeneries Ltd. (“United Greeneries”) is pleased to announce that it has received the amendment to sell dried marijuana to registered patients by Health Canada under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).
United Greeneries has previously received the authorization to cultivate cannabis under the ACMPR in June 2016 and commenced growing operations in December 2016, after the successful importation of 32 commercial cannabis varieties from Europe.
United Greeneries currently has 220kg of dried cannabis buds in storage for immediate sale and has a strategic wholesale agreement with CannTrust Holdings Inc. (CSE:TRST) in place for the first year of its production, while the Company is setting up a distribution platform for the recreational cannabis market in Canada.
The authorisation to sell under the ACMPR was the final and crucial missing piece for United Greeneries on the regulatory pathway to becoming a fully licensed producer under the ACMPR. With operations in place, immediate revenue secured and expansion in progress, management can now focus on the go forward strategy to manifest Harvest One as a leading player in the international cannabis industry.
Andreas Gedeon, Managing Director and CEO
About Harvest One Cannabis Inc. (TSX.V: HVST)
Harvest One controls operations across the entire cannabis value chain through three business units, with Harvest One serving as the umbrella company over horticultural arm United Greeneries and medical arm Satipharm AG. Each business is strategically located in favourable jurisdictions with supportive regulatory frameworks in place. United Greeneries has received a Canadian medicinal cannabis cultivation license, making Harvest One one of only a few companies globally with the capacity to commercially cultivate cannabis in a federally regulated environment.
Original press release: https://globenewswire.com/news-release/2017/10/13/1145729/0/en/Harvest-One-s-Wholly-Owned-Subsidiary-United-Greeneries-Receives-ACMPR-Sales-and-Distribution-Amendment-from-Health-Canada.html
For fact-based information on Harvest One, view the company’s sponsored Investor Dashboard.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.